The influence of developmental haemostasis on the laboratory diagnosis and management of haemostatic disorders during infancy and childhood

Clinics in Laboratory Medicine

Volumn 19, Issue 1, 1999, Pages 39-69

  Male, C ^a   Johnston, M ^a   Sparling, C ^a   Brooker, L ^a   Andrew, M ^a   Massicotte, P ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLEEDING DISORDER; BLOOD CLOTTING; FIBRINOLYSIS; HUMAN; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOCYTE COUNT; THROMBOSIS;

EID: 0032964707     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30128-8     Document Type: Review

References (150)

1. Aarts P.A. Bolhuis P.A. Sakariassen K.S. Red blood cell size is important for adherence of blood platelets to artery subendothelium Blood 62 1983 214 217
2. Adcock D.M. Brozna J. Marlar R.A. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis Semin Thromb Haemost 16 1990 333 340
3. Adcock D.M. Hicks M.J. Dermatopathology of skin necrosis associated with purpura fulminans Semin Thromb Haemost 16 1990 283 292
4. Alarcon Segovia D. Deleze M. Oria C.V. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients Medicine 68 1989 353 365
5. Alebouyeh M. Lusher J.M. Ameri M.R. The effect of 5-hydroxytryptamine and epinephrine on newborn platelets Eur J Pediatr 128 1978 163 168
6. Andrew M. Platelets in newborns: Physiology and pathology Luban N. Transfusion Sciences ed 12 1991 Pergamon Press Elmsford, NY 207 230
7. Andrew M. Brooker L.A. Hemostatic complications in renal disorders of the young Pediatr Nephrol 10 1996 88 99
8. Andrew M. Brooker L. Leaker M. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration Thromb Haemost 68 1992 325 330
9. Andrew M. Castle V. Mitchell L. Modified bleeding time in the infant Am J Hematol 30 1989 190 191
10. Andrew M. David M. Adams M. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE Blood 83 1994 1251 1257
11. Andrew M. David M. deVeber G. Arterial thromboembolic complications in paediatric patients Thromb Haemost 78 1997 715 725
12. Andrew M. deVeber G. Pediatric Thrombembolism and Stroke Protocols 1997 B. C. Decker Hamilton, NY
13. Andrew M. Karpatkin M. A simple screening test for evaluating prolonged partial thromboplastin times in newborn infants J Pediatr 101 1982 610 612
14. Andrew M. Marzinotto V. Brooker L.A. Oral anticoagulant therapy in pediatric patients: A prospective study Thromb Haemost 71 1994 265 269
15. Andrew M. Marzinotto V. Massicotte P. Heparin therapy in pediatric patients: A prospective cohort study Pediatr Res 35 1994 78 83
16. Andrew M. Marzinotto V. Pencharz P. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home J Pediatr 126 1995 358 363
17. Andrew M. Massicotte M.P. deVeber G. 1-800-NO-CLOTS: A quaternary care solution to a new tertiary care disease: Childhood thrombophilia [abstract] Thromb Haemost 77 1997 727
18. Andrew M. Mitchell L. Berry L. An anticoagulant dermatan sulphate proteoglycan circulates in the pregnant woman and her fetus J Clin Invest 89 1992 321 326
19. Andrew M. Mitchell L. Vegh P. Thrombin regulation in children differs from adults in the absence and presence of heparin Thromb Haemost 72 1994 836 842
20. Andrew M. Ofosu F. Schmidt B. Heparin clearance and ex vivo recovery in newborn piglets and adult pigs Thromb Res 52 1988 517 527
21. Andrew M. Paes B. Bowker J. Evaluation of an automated bleeding time device in the newborn Am J Hematol 35 1990 275 277
22. Andrew M. Paes B. Johnston M. Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1990 95 104
23. Andrew M. Paes B. Milner R. Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
24. Andrew M. Paes B. Milner R. Development of the human coagulation system in the healthy premature infant Blood 72 1988 1651 1657
25. Andrew M. Schmidt B. Mitchell L. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin Thromb Haemost 63 1990 27 30
26. Andrew M. Vegh P. Johnston M. Maturation of the hemostatic system during childhood Blood 80 1992 1998 2005
27. Angelini L. Ravelli A. Caporali R. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia Pediatrics 94 1994 500 503
28. Arnout J. Vanrusselt M. Huybrechts E. Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin Br J Haematol 87 1994 94 99
29. Asherson R.A. Khamashta M.A. Ordi-Ros J. The “primary” antiphospholipid syndrome: Major clinical and serological features Medicine 68 1989 366 374
30. Auletta M.J. Headington J.T. Purpura fulminans: A cutaneous manifestation of severe protein C deficiency Arch Dermatol 124 1988 1387 1391
31. Aurousseau M. Amiral J. Boffa M. Level of plasma thrombomodulin in neonates and children [abstract] Thromb Haemost 65 1991 1232
32. Bauer K.A. Weiss L.M. Sparrow D. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study J Clin Invest 80 1987 1527 1534
33. Bertina R.M. Koeleman B.P. Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
34. Berube C. Mitchell L. Silverman E. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: A cross-sectional study Pediatr Res 44 1998 351 356
35. Bodzenta-Lukaszyk A. Gabryelewicz A. Lukaszyk A. Nitric oxide synthase inhibition and platelet function Thromb Res 75 1994 667 672
36. Bovill E.G. Becker R. Tracy R.P. Monitoring thrombolytic therapy Prog Cardiovasc Dis 34 1992 279 294
37. Bovill E.G. Soll R.F. Lynch M. Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate Blood 81 1993 77 83
38. Brandt J.T. Triplett D.A. Alving B. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH Thromb Haemost 74 1995 1185 1190
39. Brill-Edwards P. Ginsberg J.S. Johnston M. Establishing a therapeutic range for heparin therapy Ann Intern Med 119 1993 104 109
40. Buchanan G. Overview of ITP treatment modalities in children Blutalkohol 59 1989 96 104
41. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens Acta Haematol 17 1957 237 246
42. Cohn R.J. MacPhail A.P. Hartman E. Transfusion-related human immunodeficiency virus in patients with haemophilia in Johannesburg S Afr Med J 78 1990 653 656
43. Corby D.G. O’Barr T.P. Decreased alpha-adrenergic receptors in newborn platelets. Cause of abnormal response to epinephrine Dev Pharm Therapeutics 2 1981 215 225
44. Corrigan J.J. Jr Neonatal thrombosis and the thrombolytic system. Pathophysiology and therapy Am J Pediatr Hematol/Oncol 10 1988 83 91
45. Corrigan J.J. Jr Sleeth J.J. Jeter M. Newborn’s fibrinolytic mechanism: Components and plasmin generation Am J Hematol 32 1989 273 278
46. Daffos F. Forestier F. Kaplan C. Prenatal diagnosis and management of bleeding disorders with fetal blood sampling Am J Obstet Gynecol 158 1988 939 946
47. Dahlback B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thromboembolism Blood 85 1995 607 614
48. D’Angelo A. Selhub J. Homocysteine and thrombotic disease Blood 90 1997 1 11
49. David M. Andrew M. Venous thromboembolic complications in children: A critical review of the literature J Pediatr 123 1993 337 346
50. deVeber G. Monagle P. Chan A. Pre-thrombotic disorders in infants and children with cerebral thromboembolism Arch Neurol 55 12 1998 1539 1543
51. Dix D. Marzinotto V. Leaker M. The use of low molecular weight heparin in pediatric patients: Review of a single institution’s experience [abstract] Pediatr Res 43 1998 761
52. Edelberg J.M. Enghild J.J. Pizzo S.V. Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein J Clin Invest 86 1990 107 112
53. Ehrenforth S. Koch H.G. Rehan M. Multicentre evaluation of combined pro-thrombotic defects associated with thrombophilia in childhood [abstract] Blood 90 1997 470
54. Evans D.I. Rowlands M. Poller L. Survey of oral anticoagulant treatment in children J Clin Pathol 45 1992 707 708
55. Exner T. Rickard K.A. Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns Br J Haematol 40 1978 143 151
56. Feusner J.H. Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technique Am J Clin Pathol 74 1980 73 77
57. Fernandez F. Goudable C. Sie P. Low hematocrit and prolonged bleeding time in uraemic patients: Effect of red cell transfusions [abstract] Br J Haematol 59 1985 139 148
58. Forestier F. Daffos F. Galacteros F. Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation Pediatr Res 20 1986 342 346
59. Forestier F. Daffos E. Sole Y. Prenatal diagnosis of hemophilia by fetal blood sampling under ultrasound guidance [abstract] Haemostasis 16 1986 346 351
60. Freed M.D. Keane J.F. Rosenthal A. The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children Circulation 50 1974 565 569
61. Gattorno M. Buoncompagni A. Molinari A.C. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis, and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome Br J Rheumatol 34 1995 873 881
62. Ginsberg J.S. Wells P.S. Brill Edwards P. Antiphospholipid antibodies and venous thromboembolism Blood 86 1995 3685 3691
63. Girolami A. De Marco L. Dal Bo Zanon R. Rarer quantitative and qualitative abnormalities of coagulation Clin Hematol 14 1985 385 411
64. Goldstein J. Brown M. Familial hypercholesterolemia Stanbury J.B. Metabolic Basis of Inherited Disease 1989 McGraw Hill New York
65. Graham I.M. Daly L.E. Refsum H.M. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Group JAMA 277 1997 1775 1781
66. 3H] vitamin in rats Br J Haematol 65 1987 335 338
67. Haitas B. Baker S.G. Meyer T.E. Natural history and cardiac manifestations of homozygous familial hypercholesterolaemia Q J Med 76 1990 731 740
68. Harker L.A. Slichter S.J. The bleeding time as a screening test for evaluation of platelet function N Engl J Med 287 1972 155 159
69. Haroon Y. Shearer M.J. Rahim S. The content of phylloquinone (vitamin Ki) in human milk, cow’s milk, and infant formula foods determined by high-performance liquid chromatography J Nutr 112 1982 1105 1117
70. Hicsonmez G. Prozorova-Zamani V. Platelet aggregation in neonates with hyperbilirubinemia Scand J Haematol 24 1980 67 70
71. Hiraike H. Kimura M. Itokawa Y. Distribution of K vitamins (phylloquinone and menaquinones) in human placenta and maternal and umbilical cord plasma Am J Obstet Gynecol 158 1988 564 569
72. Hiraike H. Kimura M. Itokawa Y. Determination of K vitamins (phylloquinone and menaquinones) in umbilical cord plasma by a platinum-reduction column J Chromotogr 430 1988 143 148
73. Hirsh J. Heparin N Engl J Med 324 1991 1565 1574
74. Hirsh J. Oral anticoagulant drugs. Review article N Engl J Med 324 1991 1865 1875
75. Hirsh J. Raschke R. Warkentin T. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety Chest 108 1995 258S 275S
76. Jacqz E.M. Barrow S.E. Dollery C.T. Prostacyclin concentrations in cord blood and in the newborn Pediatrics 76 1985 954 957
77. Johnston M. Zipursky A. Microtechnology for the study of the blood coagulation system in newborn infants Can J Med Tech 42 1980 159 164
78. Jones C.R. McCabe R. Hamilton C.A. Maternal and fetal platelet responses and adrenoreceptor binding characteristics Thromb Haemost 53 1985 95 98
79. Katz J.A. Moake J.L. McPherson P.D. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma Blood 73 1989 1851 1858
80. Kluft C. Nieuwenhuis H.K. Groeneveld E. Alpha-2-antiplasmin Enschede: Dis-functional alpha-2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder J Clin Invest 80 1987 1391 1400
81. Koepke J.A. Partial thromboplastin time test—proposed performance guidelines. ICSH panel on the APTT Thromb Haemost 55 1986 143 144
82. Kolindewala J.K. Das B.K. Dube R.K. Blood fibrinolytic activity in neonates: Effect of period of gestation, birth weight, anoxia and sepsis Ind Pediatr 24 1987 1029 1033
83. Kontiainen S. Miettinen A. Seppala I. Antiphospholipid antibodies in children Acta Paediatr 85 1996 614 615
84. 2 inhibits cord blood platelet function Haematologica (Pavia) 73 1988 207 210
85. Leaker M. Brooker L. Ofosu K. Anisoylated streptokinase-plasminogen activator complex offers no advantage over streptokinase for fibrin clot lysis in cord plasma Pediatr Research 37 4 1995 283a
86. Leaker M. Brooker L.A. Mitchell L.G. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation Transplantation 60 1995 144 147
87. Lehman M.F. Kolb K.W. Barnhart G. Warfarin absorption in a patient with short-bowel syndrome Clin Pharm 4 1985 325 326
88. 2-macroglobulin-protease complexes in infants Biol Neonate 51 1987 149 155
89. Loizou S. McCrea J.D. Rudge A.C. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results Clin Exp Immunol 62 1985 738 745
90. Male C. Kapiotis S. Eichinger S. Clinical significance and course of lupus anticoagulants in children [abstract] Thromb Haemost 77 suppl 1997 397 398
91. Manco Johnson M.J. Nuss R. Lupus anticoagulant in children with thrombosis Am J Hematol 48 1995 240 243
92. Mandelbrot L. Guillaumont M. Leclercq M. Placental transfer of vitamin Ki and its implications in fetal haemostasis Thromb Haemost 60 1988 39 43
93. Massicotte M.P. Leaker M. Marzinotto V. Enhanced thrombin regulation during warfarin therapy in children compared to adults Thromb Haemost 80 1998 570 574
94. Massicotte M. Marzinotto V. Adams M. Coumarin suppresses thrombin regulation to a greater extent in children compared to adults [abstract] Thromb Haemost 73 1995 1117
95. Massicotte P. Marzinotto V. Vegh P. Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor J Pediatr 127 1995 389 394
96. McDonald M.M. Jacobson L.J. Hay W.W. Heparin clearance in the newborn Pediatr Res 15 1981 1015 1018
97. Michelson A.D. Bovill E. Monagle P. Antithrombotic therapy in children Chest 114 Suppl. 1998 748s 769s
98. Mielke C.J. Aspirin prolongation of the template bleeding time: Influence of venostasis and direction of incision Blood 60 1982 1139 1142
99. Miletich J. Sherman L. Broze G. Jr Absence of thrombosis in subjects with heterozygous protein C deficiency N Engl J Med 317 1987 991 996
100. Mitchell L. Pio vella F. Ofosu F. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III deficient children Blood 78 1991 2299 2304
101. Montes de Oca M.A. Babron M.C. Bletry O. Thrombosis in systemic lupus erythematosus: A French collaborative study Arch Dis Child 66 1991 713 717
102. Mudd S.H. Skovby F. Levy H.L. The natural history of homocysteinuria due to cystathionine b-synthase deficiency Am J Hum Genet 37 1985 1 31
103. Muller A.D. van Doorm J.M. Hemker H.C. Heparin-like inhibitor of blood coagulation in normal newborn Nature 267 1977 616 617
104. Nitschmann E. Berry L. Bridge S. Morphologic and biochemical features affecting the antithrombotic properties of the inferior vena cava of rabbit pups and adult rabbits Pediatr Res 43 1998 62 67
105. Nowak-Gottl U. Auberger K. Gobel U. Inherited defects of the protein C anticoagulant system in childhood thromboembolism Eur J Pediatr 155 1996 921 927
106. Nowak-Gottl U. Debus O. Findeisen M. Lipoprotein (a): Its role in childhood thromboembolism Pediatrics 99 1997 e11
107. Orth-Gomer K. Mittleman M.A. Schenck-Gustafsson K. Lipoprotein (a) as a determinant of coronary heart disease in young women Circulation 95 1997 329 334
108. Pinto M. Mitchell L. McCusker P. Standardization of prothrombin times in newborn infants J Pediatr 123 1993 310 312
109. Poller L. INR-calibration of the therapeutic range Wessler S. Becker C. Nemerson Y. The New Dimensions of Warfarin Prophylaxis 1987 Plenum Press New York 95 112
110. Poort S.R. Rosendaal F.R. Reitsma P.H. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
111. Rajasekhar D. Barnard M.R. Bednarek F.J. Platelet hyporeactivity in very low birth weight neonates Thromb Haemost 77 1997 1002 1007
112. Rajasekhar D. Kestin A.S. Bednarek F.J. Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood Thromb Haemost 72 1994 957 963
113. Raschke R.A. Reilly B.M. Guidry J.R. The weight-based heparin dosing nomogram compared with a “standard care” nomogram. A randomized controlled trial Ann Intern Med 119 1993 874 881
114. Ravelli A. Caporali R. Di Fuccia G. Anticardiolipin antibodies in pediatric systemic lupus erythematosus Arch Pediatr Adolesc Med 148 1994 398 402
115. Reddy M.N. Reference ranges for total homocysteine in children Clin Chim Acta 262 1997 153 155
116. Rees D.C. Cox M. Clegg J.B. World distribution of factor V Leiden Lancet 346 1995 1133 1134
117. Reitsma P.H. Bernardi F. Doig R.G. Protein C deficiency: A database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH Thromb Haemost 73 1995 876 889
118. Reverdiau-Moalic P. Delahousse B. Body G. Evolution of blood coagulation activators and inhibitors in the healthy human fetus Blood 88 1996 900 906
119. Reverdiau-Moalic P. Gruel Y. Delahousse B. Comparative study of the fibrinolytic system in human fetuses and in pregnant women Thromb Res 61 1991 489 499
120. Ridker P.M. Hennekens C.H. Lindpainter K. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men N Engl J Med 95 1995 912 917
121. Ridker P.M. Hennekens C.H. Selhub J. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism [see comments] Circulation 95 1997 1777 1782
122. Ridker P.M. Hennekens C.H. Stampfer M.J. A prospective study of lipoprotein (a) and the risk of myocardial infarction JAMA 270 1993 2195 2199
123. Saito H. Alpha 2-plasmin inhibitor and its deficiency states J Lab Clin Med 112 1988 671 678
124. Sanders J.M. Holtkamp C.A. Buchanan G.R. The bleeding time may be longer in children than in adults Am J Pediatr Hematol Oncol 12 1990 314 318
125. 1 in low birth weight infants J Pediatr 107 1985 608 611
126. Schleef R.R. Higgins D.L. Pillemer E. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor J Clin Invest 83 1989 1747 1752
127. Schieider M.A. Nachman R.L. Jaffe E.A. A clinical study of the lupus anticoagulant Blood 48 1976 499 509
128. Schmidt B. Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry Pediatrics 96 1995 939 943
129. Schmidt B. Andrew M. Report of scientific and standardization subcommittee on neonatal hemostasis diagnosis and treatment of neonatal thrombosis Thromb Haemost 67 1992 381 382
130. Schmidt B. Mitchell L. Ofosu F.A. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma Thromb Haemost 62 1989 1074 1077
131. Schmidt B. Mitchell L. Ofosu F. Standard assays underestimate the concentration of heparin in neonatal plasma J Lab Clin Med 112 1988 641 643
132. Schmidt B. Ofosu F.A. Mitchell L. Anticoagulant effects of heparin in neonatal plasma Pediatr Res 25 1989 405 408
133. Seaman D.E. Londino A.V. Jr Kwoh C.K. Antiphospholipid antibodies in pediatric systemic lupus erythematosus Pediatrics 96 1995 1040 1045
134. Sprecher D.L. Schaefer E.J. Kent K.M. Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients Am J Cardiol 54 1984 20 30
135. Stuart M.J. Dusse J. Clark D.A. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine Pediatr Res 18 1984 823 826
136. Sutherland J.M. Glueck H.I. Gleser G. Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis Am J Dis Child 113 1967 524 533
137. Svensson P.T. Dahlback B. Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522
138. Thiagarajan P. Pengo V. Shapiro S.S. The use of dilute Russell Viper Venom time for the diagnosis of lupus anticoagulants Blood 68 1986 869 874
139. Turner Gomes S. Nitschmann E. Benson L. Heparin is cleared faster in children with congenital heart disease than adults [abstract] J Am Coll Cardiol 21 1993 59
140. Uttenreuther-Fisher M.M. Ziemer S. Gaedicke G. Resistance to activated protein C (APCR): Reference values of APC ratios for children Throm Haemost 76 1996 813 814
141. Van Boven H.H. Lane D.A. Antithrombin and its inherited deficiency states Semin Hematol 34 1997 188 204
142. Vilaseca M.A. Moyano D. Ferrer I. Total homocysteine in pediatric patients Clin Chem 43 1997 690 692
143. 1 supplements given to the mother Pediatr Res 22 1987 513 517
144. Von Kries R. Stannigel H. Gobel U. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation Eur J Pediatr 144 1985 191 194
145. Weinstein M.J. Blanchard R. Moake J.L. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenia purpura Br J Haematol 72 1989 68 72
146. Weissbach G. Harenberg J. Wendisch J. Tissue factor pathway inhibitor in infants and children Thromb Res 73 1994 441 446
147. West R.J. Lloyd J.K. Hypercholesterolemia in childhood Adv Pediatr 26 1979 1 34
148. Xu L. Delorme M. Berry L. Thrombin generation in newborn and adult plasma in the presence of an endothelial surface [abstract] Thromb Haemost 65 1991 1230
149. Zipursky A. Jaber H.M. The haematology of bacterial infection in newborn infants Clin Hematol 7 1978 175 193
150. Zoller B. Svensson P.J. He X. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524